Stage 2 prostate adenocarcinoma is localized, with a nearly 100% five-year relative survival rate. Diagnosis uses the TNM system, PSA levels, and Gleason score to determine cancer stage and risk.

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

The ArteraAI Prostate Test uses AI to analyze biopsy images, predicting hormone therapy benefits for prostate cancer patients. Approved in the US and UK, the test aids early diagnostic decisions, ...

If a person has an “aggressive” prostate cancer with a Gleason score of 9, what does that mean? What’s the outlook when it comes to survival rate and prognosis? Every cancer survivor is unique, of ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...